2024 Q2 Form 10-Q Financial Statement

#000163528224000107 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $103.1M $106.7M $105.5M
YoY Change -3.1% 1.17% 7.76%
Cost Of Revenue $42.18M $42.91M $39.34M
YoY Change 7.2% 9.08% 5.74%
Gross Profit $60.94M $63.83M $66.17M
YoY Change -9.14% -3.53% 9.0%
Gross Profit Margin 59.1% 59.8% 62.71%
Selling, General & Admin $56.91M $57.54M $52.71M
YoY Change 1.35% 9.18% 2.04%
% of Gross Profit 93.38% 90.15% 79.65%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $860.0K $873.0K $613.0K
YoY Change 35.22% 42.41% 6.24%
% of Gross Profit 1.41% 1.37% 0.93%
Operating Expenses $61.72M $60.47M $55.48M
YoY Change 9.92% 8.98% 1.32%
Operating Profit -$775.0K $3.363M $10.69M
YoY Change -107.09% -68.53% 79.82%
Interest Expense -$1.483M $1.341M -$1.339M
YoY Change -12.07% -200.18% 228.09%
% of Operating Profit 39.88% -12.53%
Other Income/Expense, Net $1.492M $964.0K $528.0K
YoY Change 157.24% 82.58% 152.63%
Pretax Income -$766.0K $2.986M $9.874M
YoY Change -108.34% -69.76% 84.8%
Income Tax $382.0K $1.669M $4.235M
% Of Pretax Income 55.89% 42.89%
Net Earnings -$1.100M $1.317M $5.639M
YoY Change -125.77% -76.64% 82.67%
Net Earnings / Revenue -1.07% 1.23% 5.34%
Basic Earnings Per Share -$0.01 $0.01 $0.06
Diluted Earnings Per Share -$0.01 $0.01 $0.06
COMMON SHARES
Basic Shares Outstanding 90.41M shares 89.88M shares 88.81M shares
Diluted Shares Outstanding 90.50M shares 90.56M shares 89.06M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $134.2M $129.0M $135.0M
YoY Change -4.6% -4.41% -14.61%
Cash & Equivalents $134.2M $129.0M $116.2M
Short-Term Investments $0.00 $0.00 $18.79M
Other Short-Term Assets $41.76M $40.59M $37.52M
YoY Change 6.38% 8.18% 12.94%
Inventory
Prepaid Expenses $24.64M $22.95M $19.91M
Receivables $86.96M $78.79M $89.32M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $262.9M $248.4M $261.8M
YoY Change -0.78% -5.12% -7.35%
LONG-TERM ASSETS
Property, Plant & Equipment $18.14M $15.97M $12.88M
YoY Change 27.13% 24.0% -24.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $86.31M $86.84M $93.43M
YoY Change -5.77% -7.05% 5.9%
Total Long-Term Assets $104.5M $102.8M $106.3M
YoY Change -1.33% -3.29% 1.02%
TOTAL ASSETS
Total Short-Term Assets $262.9M $248.4M $261.8M
Total Long-Term Assets $104.5M $102.8M $106.3M
Total Assets $367.4M $351.2M $368.1M
YoY Change -0.94% -4.59% -5.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.523M $3.612M $5.956M
YoY Change -2.35% -39.36% 64.53%
Accrued Expenses $53.94M $51.99M $58.43M
YoY Change -7.13% -11.03% -6.94%
Deferred Revenue $240.4M $230.0M $257.3M
YoY Change -7.22% -10.61% 3.54%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.093M $5.914M $5.349M
YoY Change -50.58% 10.56% 45.99%
Total Short-Term Liabilities $303.2M $292.8M $329.6M
YoY Change -7.89% -11.16% 2.99%
LONG-TERM LIABILITIES
Long-Term Debt $68.73M $62.78M $68.56M
YoY Change 2.41% -8.43% -12.96%
Other Long-Term Liabilities $1.650M $1.758M $1.896M
YoY Change -95.49% -7.28% -33.52%
Total Long-Term Liabilities $70.38M $64.54M $70.45M
YoY Change -32.12% -8.4% -13.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $303.2M $292.8M $329.6M
Total Long-Term Liabilities $70.38M $64.54M $70.45M
Total Liabilities $403.5M $387.5M $438.2M
YoY Change -6.8% -11.57% -5.78%
SHAREHOLDERS EQUITY
Retained Earnings -$202.0M -$200.9M -$222.6M
YoY Change -7.47% -9.76% -0.03%
Common Stock $9.000K $9.000K $9.000K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.116M
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity -$36.12M -$36.31M -$70.12M
YoY Change
Total Liabilities & Shareholders Equity $367.4M $351.2M $368.1M
YoY Change -0.94% -4.59% -5.08%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$1.100M $1.317M $5.639M
YoY Change -125.77% -76.64% 82.67%
Depreciation, Depletion And Amortization $860.0K $873.0K $613.0K
YoY Change 35.22% 42.41% 6.24%
Cash From Operating Activities $6.257M $11.09M $8.643M
YoY Change -52.26% 28.29% -81.15%
INVESTING ACTIVITIES
Capital Expenditures $856.0K $1.172M $1.029M
YoY Change -19.7% 13.9% -312.16%
Acquisitions
YoY Change
Other Investing Activities $0.00 $9.826M $683.0K
YoY Change -100.0% 1338.65%
Cash From Investing Activities -$856.0K $8.654M -$346.0K
YoY Change 7.81% -2601.16% -28.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.849M -$1.775M -$1.101M
YoY Change -226.79% 61.22% -73.13%
NET CHANGE
Cash From Operating Activities 6.257M $11.09M $8.643M
Cash From Investing Activities -856.0K $8.654M -$346.0K
Cash From Financing Activities 2.849M -$1.775M -$1.101M
Net Change In Cash 8.250M $13.58M $7.161M
YoY Change -18.03% 89.65% -81.39%
FREE CASH FLOW
Cash From Operating Activities $6.257M $11.09M $8.643M
Capital Expenditures $856.0K $1.172M $1.029M
Free Cash Flow $5.401M $9.916M $7.614M
YoY Change -55.14% 30.23% -83.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAccruedLiabilitiesCurrent
CY2024Q1 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAccruedLiabilitiesCurrent
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
42914000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39343000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
63831000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
66169000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
39141000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
34479000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18401000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18227000 usd
CY2024Q1 us-gaap Restructuring Costs
RestructuringCosts
0 usd
CY2023Q1 us-gaap Restructuring Costs
RestructuringCosts
59000 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
2926000 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
2719000 usd
CY2024Q1 rmni Litigation Costs Net Of Refunds And Recoveries
LitigationCostsNetOfRefundsAndRecoveries
-2926000 usd
CY2023Q1 rmni Litigation Costs Net Of Refunds And Recoveries
LitigationCostsNetOfRefundsAndRecoveries
-2719000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
60468000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
55484000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3363000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
10685000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
1341000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1339000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
964000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
528000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2986000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9874000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1669000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4235000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1317000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5639000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-991000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
139000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
300000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-775000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
626000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5003000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1317000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5639000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89754000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88690000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90560000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89061000 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-39496000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-77170000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-36312000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-70119000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1317000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5639000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2558000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1976000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
873000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
613000 usd
CY2024Q1 rmni Accretion And Amortization Of Debt Discount And Issuance Costs
AccretionAndAmortizationOfDebtDiscountAndIssuanceCosts
243000 usd
CY2023Q1 rmni Accretion And Amortization Of Debt Discount And Issuance Costs
AccretionAndAmortizationOfDebtDiscountAndIssuanceCosts
240000 usd
CY2024Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-759000 usd
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
496000 usd
CY2024Q1 rmni Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiabilities
-1112000 usd
CY2023Q1 rmni Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiabilities
-1147000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-39763000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-26945000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3517000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
425000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-2509000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-1427000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2342000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2087000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-8422000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-14844000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-29281000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-12484000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11088000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8643000 usd
CY2024Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1172000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1029000 usd
CY2024Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
7458000 usd
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
7713000 usd
CY2024Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
17284000 usd
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
8396000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8654000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-346000 usd
CY2024Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1688000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1125000 usd
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
87000 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
47000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
71000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1775000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1101000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4386000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-35000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13581000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7161000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115852000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109434000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
129433000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
116595000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
1068000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1112000 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
502000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
2794000 usd
CY2024Q1 rmni Capital Expenditures Incurred But Not Yet Paid Increase Decrease
CapitalExpendituresIncurredButNotYetPaidIncreaseDecrease
7000 usd
CY2023Q1 rmni Capital Expenditures Incurred But Not Yet Paid Increase Decrease
CapitalExpendituresIncurredButNotYetPaidIncreaseDecrease
0 usd
CY2024Q1 rmni Working Capital Surplus Deficit
WorkingCapitalSurplusDeficit
44500000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1300000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
129400000 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
230000000 usd
CY2024Q1 rmni Cost Of Goods And Services Sold As Percentage Of Revenue
CostOfGoodsAndServicesSoldAsPercentageOfRevenue
0.40
CY2024Q1 rmni Lessee Lease Liability Payments Due Next Rolling Twelve Months
LesseeLeaseLiabilityPaymentsDueNextRollingTwelveMonths
5500000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires the Company to make judgments, assumptions, and estimates that affect the amounts reported in its consolidated financial statements and accompanying notes. The Company bases its estimates and assumptions on current facts, historical experience, and various </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other factors that it believes are reasonable under the circumstances to determine the carrying values of assets and liabilities that are not readily apparent from other sources. The Company’s accounting estimates include, but are not necessarily limited to, valuation of accounts receivable, valuation assumptions for stock options and leases, deferred income taxes and the related valuation allowances, and the evaluation and measurement of contingencies. To the extent there are material differences between the Company’s estimates and actual results, the Company’s future consolidated results of operations may be affected.</span></div>
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
41493000 usd
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
40726000 usd
CY2024Q1 rmni Capitalized Commissions
CapitalizedCommissions
2504000 usd
CY2023Q1 rmni Capitalized Commissions
CapitalizedCommissions
3162000 usd
CY2024Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
5013000 usd
CY2023Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
4589000 usd
CY2024Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
38984000 usd
CY2023Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
39299000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
286974000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
299921000 usd
CY2024Q1 us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
74077000 usd
CY2023Q1 us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
92972000 usd
CY2024Q1 rmni Contract With Customer Liability Revenue Recognized Including Current Billings
ContractWithCustomerLiabilityRevenueRecognizedIncludingCurrentBillings
106745000 usd
CY2023Q1 rmni Contract With Customer Liability Revenue Recognized Including Current Billings
ContractWithCustomerLiabilityRevenueRecognizedIncludingCurrentBillings
105512000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
254306000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
287381000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
556900000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
254300000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
556100000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
287400000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
230000000 usd
CY2024Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
7158000 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
7963000 usd
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4351000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3551000 usd
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
367000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
360000 usd
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
968000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1771000 usd
CY2024Q1 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
82000 usd
CY2023Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
82000 usd
CY2024Q1 rmni Other Accrued Expenses Current
OtherAccruedExpensesCurrent
5033000 usd
CY2023Q4 rmni Other Accrued Expenses Current
OtherAccruedExpensesCurrent
4401000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
17959000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
18128000 usd
CY2022Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
3584000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
184000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
248000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
406000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
108000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
136000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
12283000 shares
CY2024Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
17000 usd
CY2023Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
21000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
1341000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1339000 usd
CY2024Q1 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
200000 usd
CY2023Q1 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
200000 usd
CY2022Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
15000000 usd
CY2022Q2 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P2Y
CY2022Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000 usd
CY2022Q2 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P4Y
CY2022Q1 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
15000000 usd
CY2022Q1 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
15000000 usd
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0 shares
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
3600000 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.64
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0406
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
3.11
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
8481000 shares
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2558000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1976000 usd
CY2024Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
3400000 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5.64
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.559
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.429
CY2023Q4 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
12000000 usd
CY2023Q4 us-gaap Longterm Purchase Commitment Period
LongtermPurchaseCommitmentPeriod
P3Y
CY2023Q4 us-gaap Longterm Purchase Commitment Period
LongtermPurchaseCommitmentPeriod
P3Y
CY2024Q1 us-gaap Purchase Obligation
PurchaseObligation
11000000 usd
CY2024Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
900000 usd
CY2023Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
800000 usd
CY2024Q1 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
8300000 usd
CY2023Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
9300000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1317000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5639000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89754000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88690000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90560000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89061000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11396000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11208000 shares
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
14815000 usd
CY2023Q4 us-gaap Aoci Debt Securities Available For Sale Without Allowance For Credit Loss Cumulative Gain Loss After Tax
AociDebtSecuritiesAvailableForSaleWithoutAllowanceForCreditLossCumulativeGainLossAfterTax
99000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
14914000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
106745000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
105512000 usd
CY2024Q1 rmni Lessee Operating Lease Terms Days Notice Required To Terminate
LesseeOperatingLeaseTermsDaysNoticeRequiredToTerminate
30 day
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1112000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1147000 usd
CY2024Q1 rmni Other Lease Cost
OtherLeaseCost
113000 usd
CY2023Q1 rmni Other Lease Cost
OtherLeaseCost
48000 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
1225000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
1195000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5257000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5941000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4357000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4321000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5815000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6841000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
10172000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
11162000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M8D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.096
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
5095000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
3228000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
2486000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
359000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
307000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
0 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11475000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1303000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
10172000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1400000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1100000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001635282-24-000107-index-headers.html Edgar Link pending
0001635282-24-000107-index.html Edgar Link pending
0001635282-24-000107.txt Edgar Link pending
0001635282-24-000107-xbrl.zip Edgar Link pending
exhibit101q12024amendedand.htm Edgar Link pending
exhibit102q12024amendedand.htm Edgar Link pending
exhibit311q12024.htm Edgar Link pending
exhibit312q12024.htm Edgar Link pending
exhibit321q12024.htm Edgar Link pending
exhibit322q12024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmni-20240331.htm Edgar Link pending
rmni-20240331.xsd Edgar Link pending
Show.js Edgar Link pending
toc1.jpg Edgar Link pending
toc2.jpg Edgar Link pending
toc3.jpg Edgar Link pending
toc4.jpg Edgar Link pending
rmni-20240331_def.xml Edgar Link unprocessable
rmni-20240331_lab.xml Edgar Link unprocessable
rmni-20240331_pre.xml Edgar Link unprocessable
rmni-20240331_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
rmni-20240331_cal.xml Edgar Link unprocessable